FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+12.44%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$620M
AUM Growth
+$620M
(-3.5%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-19.18%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
63
New
8
Increased
6
Reduced
34
Closed
4
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$8.32M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$5.74M |
| 3 |
Veracyte
VCYT
|
$2.92M |
| 4 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
$2.43M |
| 5 |
CLLS
Cellectis
CLLS
|
$2.15M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$70.3M |
| 2 |
NeoGenomics
NEO
|
$22.4M |
| 3 |
AtriCure
ATRC
|
$14.4M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$13.6M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$9.28M |
Sector Composition
| 1 | Healthcare | 83.6% |
| 2 | Communication Services | 3.41% |
| 3 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$429B
| $302K | 0.05% |
2,183
| – | – |
|
52
Sanofi
SNY
$122B
| $300K | 0.05% |
6,720
| – | – |
|
53
Amgen
AMGN
$153B
| $229K | 0.04% |
1,105
| – | – |
|
54
Revvity
RVTY
$9.68B
| $221K | 0.04% |
+2,270
| New | +$221K |
|
55
Elevance Health
ELV
$72.4B
| $220K | 0.04% |
+803
| New | +$220K |
|
56
HCA Healthcare
HCA
$95.4B
| $210K | 0.03% |
+1,513
| New | +$210K |
|
57
Teleflex
TFX
$5.57B
| $208K | 0.03% |
783
| – | – |
|
|
HRC
58
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $202K | 0.03% |
+2,144
| New | +$202K |
|
|
STRM
59
DELISTED
Streamline Health Solutions
STRM
| $47K | 0.01% |
2,647
-112,297
| -98% | -$1.99M |
|
60
IRIDEX
IRIX
$23.6M
| – | – |
-198,581
| Closed | -$1.38M |
|
|
NVRO
61
DELISTED
NEVRO CORP.
NVRO
| – | – |
-116,224
| Closed | -$9.28M |
|
|
CELG
62
DELISTED
Celgene Corp
CELG
| – | – |
-14,742
| Closed | -$1.17M |
|
|
XLVS
63
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| – | – |
-17,285
| Closed | -$2.22M |
|